Invention Grant
- Patent Title: PD-L1 binding polypeptides for imaging
-
Application No.: US15529260Application Date: 2015-11-24
-
Publication No.: US10406251B2Publication Date: 2019-09-10
- Inventor: Paul E. Morin , David Donnelly , Dasa Lipovsek , Jochem Gokemeijer , Maria N. Jure-Kunkel , David Fabrizio , Martin C. Wright , Douglas Dischino , Samuel J. Bonacorsi, Jr. , Ralph Adam Smith , Virginie Lafont , Daniel Cohen
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Cynthia L. Kanik
- International Application: PCT/US2015/062485 WO 20151124
- International Announcement: WO2016/086021 WO 20160602
- Main IPC: A61K51/08
- IPC: A61K51/08 ; C07K14/78 ; G01N33/60 ; G01N33/68 ; G01N33/574
Abstract:
Provided herein are novel polypeptides comprising fibronectin type III tenth (10Fn3) domains which specifically bind to Programmed Death Ligand-1 (PD-L1), as well as imaging agents based on the same for diagnostics.
Public/Granted literature
- US20170258948A1 NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING Public/Granted day:2017-09-14
Information query
